Physician profile
Igor Milosevic
NPI 1285941765
$93,762.03
in general payments reported to CMS, 2019-2025
20 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $8,166 · 2021: $7,485 · 2022: $5,518 · 2023: $5,175 · 2024: $488 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Food and Beverage: $692 · Gift: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Food and Beverage | $692.32 |
| Gift | $176.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $89,497.59 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,548.29 | 2019-2024 | Gore Synecor Biomaterial |
| Ethicon US, LLC | $419.96 | 2019-2024 | Echelon; Endopath, Linx Reflux Management System |
| Davol INC. | $212.37 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $168.66 | 2022-2023 | Eea |
| Conmed Corporation | $140.16 | 2019-2025 | Airseal |
| Becton, Dickinson and Company | $135.95 | 2024 | Phasix Mesh |
| Elucent Medical | $103.20 | 2025 | |
| Bard Peripheral Vascular, INC. | $102.28 | 2019 | |
| Braintree Laboratories, INC. | $100.88 | 2019-2022 | |
| Allergan, INC. | $100.22 | 2019-2021 | |
| Endogastric Solutions, INC | $67.62 | 2022 | |
| Integra Lifesciences Corporation | $30.70 | 2021 | |
| Boston Scientific Corporation | $28.42 | 2022 | |
| Lilly USA, LLC | $26.00 | 2025 | Omvoh |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.47 | 2025 | Xifaxan |
| Acell, INC. | $16.13 | 2019 | |
| Myriad Genetic Laboratories, INC. | $15.86 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $14.62 | 2021 | |
| Tei Biosciences INC | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Milosevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.